Log In
Print this Print this

Neovasculgen, cambiogenplasmid

  Manage Alerts
Collapse Summary General Information
Company Human Stem Cells Institute
DescriptionPlasmid vector containing the VEGF gene
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentMarketed
Standard IndicationPeripheral vascular disease (PVD)
Indication DetailsTreat peripheral arterial disease (PAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today